No abstract available
Keywords:
alternative medicine; complementary medicine; dermatomyositis; idiopathic inflammatory myopathy; integrative medicine; myositis.
PubMed Disclaimer
Conflict of interest statement
AH is a consultant at CSL Behring and AstraZeneca, and an investigator for Priovant.
References
-
-
Chang C.M., Shih P.H., Chen T.J., Ho W.C., Yang C.P. Integrated therapy decreases the mortality of patients with polymyositis and dermatomyositis: a Taiwan-wide population-based retrospective study. J Ethnopharmacol. 2019;236:70–81. doi: 10.1016/j.jep.2019.02.042.
-
DOI
-
PubMed
-
-
Varjú C., Pethö E., Kutas R., Czirják L. The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil. 2003;17(1):83–87. doi: 10.1191/0269215503cr572oa.
-
DOI
-
PubMed
-
-
Kong S.S., Pham T., Fortis A., Raval A., Bhanusali N. Yoga as a novel adjuvant therapy for patients with idiopathic inflammatory myopathies. Int J Yoga. 2021;14(1):75–82. doi: 10.4103/ijoy.IJOY_78_20.
-
DOI
-
PMC
-
PubMed
-
-
Bax C.E., Chakka S., Concha J.S.S., Zeidi M., Werth V.P. The effects of immunostimulatory herbal supplements on autoimmune skin diseases. J Am Acad Dermatol. 2021;84(4):1051–1058. doi: 10.1016/j.jaad.2020.06.037.
-
DOI
-
PMC
-
PubMed
-
-
Ravishankar A., Bax C., Grinnell M., et al. Spirulina use and its temporal association with dermatomyositis exacerbation. J Invest Dermatol. 2021;141(5):S74.